Delivery Order SPE2DB20D9135-SPE2DB22FD3AG

Award Date 5/20/22
Potential Completion Date 6/13/22
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,356.60 contract is for the supply of 200-unit vials of Botox to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of 100-unit vials of Botox to fulfill the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's broader $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,768.88, is for the provision of 100-unit vials of the drug Botox to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order worth $16,613.28 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,537.76 contract covers the delivery of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities worldwide. The award is part of DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $51,748.00, is for the delivery of 200-unit vials of Botox. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,688.80 contract is for the delivery of 100-unit vials of Botox, with a period of performance through August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $11,075.52, is for the delivery of 100-unit vials of Botox to support the medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,356.60 contract is for the delivery of 200-unit vials of Botox to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD3AG
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,356.60, covers the supply of 200-unit vials of Botox to support the recurring pharmaceutical needs of military medical facilities.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows for the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the medical supply requirements of the Department of Defense (DoD) healthcare system. This contract does not have a set-aside designation. Through this and other prime vendor agreements, DMS Pharmaceutical Group provides a diverse portfolio of medications, from common drugs to specialized pharmaceuticals and medical supplies, directly to DoD and Department of Veterans Affairs (VA) healthcare facilities worldwide.

Generated 1/9/25, 9:17 AM